Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT
NCT06303284
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Ankle Fractures
Interventions
DRUG:
subcutaneous Teriparatide injection
OTHER:
placebo
Sponsor
University of Calgary